Table 4.
Significant canonical pathways associated with seminal plasma
| Ingenuity Canonical Pathways | Ratio | Proteins |
|---|---|---|
|
Eumelanin Biosynthesis |
5E-01 |
MIF |
|
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
1.35E-02 |
MIF, FN1 |
|
Intrinsic Prothrombin Activation Pathway |
8.33E-02 |
KLK3 |
|
MSP-RON Signaling Pathway |
5.88E-02 |
KLK3 |
|
MIF-mediated Glucocorticoid Regulation |
4.76E-02 |
MIF |
|
MIF Regulation of Innate Immunity |
4E-02 |
MIF |
|
Thyroid Cancer Signaling |
3.57E-02 |
KLK3 |
|
Neurotrophin/TRK Signaling |
2.5E-02 |
KLK3 |
|
Atherosclerosis Signaling |
1.89E-02 |
CLU |
|
Prostate Cancer Signaling |
1.79E-02 |
KLK3 |
|
LXR/RXR Activation |
1.56E-02 |
CLU |
|
Human Embryonic Stem Cell Pluripotency |
1.56E-02 |
KLK3 |
|
IL-12 Signaling and Production in Macrophages |
1.54E-02 |
CLU |
|
Hepatic Fibrosis / Hepatic Stellate Cell Activation |
1.2E-02 |
FN1 |
|
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages |
1.11E-02 |
CLU |
|
Acute Phase Response Signaling |
1.06E-02 |
FN1 |
|
Clathrin-mediated Endocytosis Signaling |
1.06E-02 |
CLU |
|
ILK Signaling |
1.05E-02 |
FN1 |
| Actin Cytoskeleton Signaling | 9.01E-03 | FN1 |
Pathways associated with proteins specific to ROS- group are in bold. MSP-RON Macrophage-stimulating protein- transmembrane receptor kinase, MIF Macrophage migration inhibitory factor, TRK Tyrosine kinase, LXR/RXR Liver X receptor / retinoid X receptor, IL Interleukin, KLK3 Prostate specific antigen, CLU Clusterin, FN1 Fibronectin 1 isoform 3 preprotein.